Delivery Order SPE2DB22D3501-SPE2DB24FWC82

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,379.10 firm fixed-price delivery order is for the supply of 4,567,215,172 units of doxycycline hyclate 100 mg tablets. The contract has an ultimate completion date of February 11, 2025 and was awarded on February 10, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.93, is for the delivery of 4,566,846,892 units of Doxycycline Hyclate 100 mg tablets with an ultimate completion date of January 7, 2025. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide 4,561,973,653 units of Doxycycline Hyclate 100 mg tablets. The $24,715.00 firm fixed-price delivery order has an ultimate completion date of August 15, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,567,742,924 units of doxycycline hyclate 100 mg tablets, with a ceiling value of $2,406.37. It is a firm fixed-price delivery order contract with an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $20,707.19, is for the delivery of 4,564,945,167 units of Doxycycline 50 mg tablets. This is a firm fixed-price delivery order contract with a completion date of June 20, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of 4,567,238,309 units of Doxycycline Hyclate 100 mg tablets, valued at $2,282.83. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC enables...
This federal contract award, with ID SPE2DB22D3501|SPE2DB23FTR82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,255,906 units of doxycycline hyclate 100 mg tablets. The $1,644.16 firm-fixed-price delivery order has an ultimate completion date of December 5, 2022. This award is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office division, holds significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of 4,558,026 units of Doxycycline Hyclate 100 mg tablets. The Firm Fixed Price delivery order, valued at $1,602.03, was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 9, 2022. The contract was not set aside for any specific business category. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The delivery order, valued at $5,692.50, is for the supply of 4,564,476,139 units of Doxycycline Hyclate 100 mg tablets on a firm fixed price basis. The contract has a completion date of May 3, 2024 and was awarded on May 2, 2024 without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,074,952 units of Doxycycline Hyclate 100mg tablets. The $2,209.34 firm fixed-price contract has a period of performance through February 28, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWC82
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,050.23, is for the delivery of 4,565,032,900 units of doxycycline hyclate 100 mg tablets. This is a firm fixed-price delivery order contract with a completion date of July 1, 2024. The contract is not designated as a set-aside.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 10:06 AM